Form 13-F position report

SABRA HEALTH CARE REIT INC

Reported by H 2 CREDIT MANAGER LP

SBRA CUSIP 78573L106 Manager CIK 0001813784

Reported 900,000 shares, unchanged from the prior quarter.

Reported value 1.1%; share count 0.0% vs. the prior quarter.

Unchanged
% of reported 13F value 3.31% This manager · Q3 2026
Shares 900,000 Quarter-end amount reported
Reported value $17,748,000 Fair value at quarter end
Consecutive quarters held 15 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2023-03-31 8050000
2023-06-30 17655000
2023-09-30 12546000
2023-12-31 12843000
2024-03-31 13293000
2024-06-30 13860000
2024-09-30 16749000
2024-12-31 15588000
2025-03-31 15723000
2025-06-30 16596000
2025-09-30 16776000
2025-12-31 17046000
2026-03-31 17307000
2026-06-30 17559000
2026-09-30 17748000

Quarterly position history

How this manager's reported quarter-end position changed over time.

15 quarters
Quarterly reported position history for SABRA HEALTH CARE REIT INC held by H 2 CREDIT MANAGER LP.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Unchanged 900,000 0 (0.0%) 3.31% $17,748,000 2026-11-16
Q2 2026 Unchanged 900,000 0 (0.0%) 3.34% $17,559,000 2026-08-14
Q1 2026 Unchanged 900,000 0 (0.0%) 3.46% $17,307,000 2026-05-15
Q4 2025 Unchanged 900,000 0 (0.0%) 3.73% $17,046,000 2026-02-17
Q3 2025 Unchanged 900,000 0 (0.0%) 4.16% $16,776,000 2025-11-14
Q2 2025 Unchanged 900,000 0 (0.0%) 4.55% $16,596,000 2025-08-14
Q1 2025 Unchanged 900,000 0 (0.0%) 4.18% $15,723,000 2025-05-15
Q4 2024 Unchanged 900,000 0 (0.0%) 3.98% $15,588,000 2025-02-14
Q3 2024 Unchanged 900,000 0 (0.0%) 4.33% $16,749,000 2024-11-14
Q2 2024 Unchanged 900,000 0 (0.0%) 3.73% $13,860,000 2024-08-14
Q1 2024 Unchanged 900,000 0 (0.0%) 3.41% $13,293,000 2024-05-15
Q4 2023 Unchanged 900,000 0 (0.0%) 3.17% $12,843,000 2024-02-14
Q3 2023 Reduced 900,000 -600,000 (-40.0%) 3.47% $12,546,000 2023-11-14
Q2 2023 Added 1,500,000 +800,000 (114.3%) 5.38% $17,655,000 2023-08-14
Q1 2023 New 700,000 +700,000 (0.0%) 2.87% $8,050,000 2023-05-15

Who else reported the position

510 managers reported SABRA HEALTH CARE REIT INC for Q3 2026.

Managers reporting SABRA HEALTH CARE REIT INC in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Added 42,594,439 +980,088 0.01% $839,962,334 9 qtrs
PRINCIPAL FINANCIAL GROUP INC Reduced 23,836,388 -869,682 0.24% $470,050,373 54 qtrs
VANGUARD PORTFOLIO MANAGEMENT LLC Added 23,405,116 +52,743 0.02% $461,548,888 3 qtrs
STATE STREET CORPORATION Added 12,605,529 +299,874 < 0.01% $248,581,032 54 qtrs
VANGUARD CAPITAL MANAGEMENT LLC Added 11,389,472 +40,347 < 0.01% $224,600,388 3 qtrs
GEODE CAPITAL MANAGEMENT LLC Reduced 7,731,739 -177,433 < 0.01% $152,493,706 54 qtrs
CENTERSQUARE INVESTMENT MANAGEMENT LLC Added 7,370,376 +1,555,949 1.29% $145,343,815 4 qtrs
RUSH ISLAND MANAGEMENT LP Added 6,037,838 +1,827,308 7.56% $119,066,165 3 qtrs
Bank of America Corporation Reduced 5,238,727 -62,035 < 0.01% $103,307,693 54 qtrs
CHARLES SCHWAB INVESTMENT MANAGEMENT INC Added 5,155,856 +315,455 0.01% $101,673,480 54 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 16, 2026
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
900,000
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.